- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rosiglitazone insulin sensitizing agent
Total 2905 results
-
Daping Hospital and the Research Institute of Surgery...UnknownInfant, Newborn, NRDSChina
-
BiodelCompletedDiabetes MellitusUnited States
-
BiodelCompletedType 2 Diabetes MellitusUnited States
-
Hadassah Medical OrganizationUnknownUncontrolled Type 1 Diabetic Patients
-
Hvidovre University HospitalCompleted
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Canada Pharmaceutical Inc.; Lundbeck Canada Inc.CompletedMajor Depressive DisorderCanada
-
Second Xiangya Hospital of Central South UniversityRecruitingType1 Diabetes Mellitus | Autoimmune DiabetesChina
-
Bispebjerg HospitalThe Danish Medical Research CouncilUnknown
-
Ain Shams UniversityCompletedDiabetes Mellitus, Type 1Egypt
-
University of PittsburghWithdrawn
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS); ALS Association and other collaboratorsCompletedAmyotrophic Lateral SclerosisUnited States, Puerto Rico
-
The University of Texas Health Science Center,...CompletedDiabetes Mellitus, Type 2United States
-
Montefiore Medical CenterNational Institutes of Health (NIH)Completed
-
University Hospital, RouenNot yet recruitingObesity | Insulin ResistanceFrance
-
Novartis PharmaceuticalsActive, not recruitingKnee OsteoarthritisUnited States, Hungary, Estonia, Poland, Czechia, Latvia
-
Institut de Recherches Cliniques de MontrealCompleted
-
University of Colorado, DenverCompletedType 1 Diabetes Mellitus | Diabetic KetoacidosisUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2Israel, India, Kuwait, Turkey
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Korea, Republic of, Taiwan, Italy, Austria, Puerto Rico, Hungary, Greece, Poland, Spain, Romania, Ukraine, Argentina
-
Eli Lilly and CompanyCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Becton, Dickinson and CompanyCompleted
-
TakedaCompleted
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Netherlands
-
Capital Medical UniversityUnknown
-
University of Sao PauloCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.CompletedHyperglycemia | Systemic Inflammatory Response SyndromeBrazil
-
Eli Lilly and CompanyCompletedType 2 DiabetesChina, Australia, Korea, Republic of, India
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, United States, Puerto Rico, Australia, Taiwan, Israel, Spain, Canada, Greece, Argentina, Poland, Romania, Mexico, Slovakia, Brazil
-
Virginia Polytechnic Institute and State UniversityCompleted
-
Beneo-InstituteCompletedInfectious Disease | Diet Modification | Children, Only
-
Massachusetts General HospitalSanofiCompletedType 1 Diabetes | Dawn PhenomenonUnited States
-
University of Alabama at BirminghamNot yet recruitingCardiovascular Diseases | Obesity | Insulin Sensitivity/Resistance | Metabolic Disease | Energy Expenditure | MetabolismUnited States
-
david andrewsCompletedNeoplasms | Malignant GliomaUnited States
-
Arecor LimitedCompleted
-
Fudan UniversityUnknownDiabetic Neuropathic Pain
-
AdociaCompleted
-
Eli Lilly and CompanyCompletedA Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)Type1 Diabetes MellitusUnited States
-
Eli Lilly and CompanyCompleted
-
SanofiCompleted
-
AstraZenecaCompletedAlzheimer's Disease | MetabolismSweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Italy, United Kingdom, France, Serbia, Germany, South Africa, Canada, Ukraine, United Arab Emirates
-
AdociaCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2United States, France, Canada, Brazil, Russian Federation, Germany, Italy, Turkey, India, Mexico, Egypt, United Kingdom, Korea, Republic of, Chile, Puerto Rico
-
WockhardtWithdrawnBioequivalence in Healthy SubjectsUnited States
-
Taipei Veterans General Hospital, TaiwanCompleted
-
LI ZHAOCompletedPulmonary HypertensionChina
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States